{
    "clinical_study": {
        "@rank": "124644", 
        "brief_summary": {
            "textblock": "Patients with inflammatory bowel disease (IBD) who require methotrexate (MTX)for treatment\n      currently receive this drug by injection.  MTX is also available as a pill that can be given\n      by mouth but it is not known how well the drug enters the body in patients with Crohn's\n      disease or ulcerative colitis.  This study is being done to compare how much MTX enters the\n      body when the drug is taken by mouth compared to when it is given by injection.  If the drug\n      is well absorbed, it may allow patients to receive the drug by mouth."
        }, 
        "brief_title": "A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease", 
        "condition": "Inflammatory Bowel Disease", 
        "condition_browse": {
            "mesh_term": [
                "Inflammatory Bowel Diseases", 
                "Intestinal Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Adult or pediatric patients with IBD (CD or UC) currently receiving MTX as part of\n             their clinical care.\n\n          -  Patients must be receiving weekly MTX at a dose between 7.5 and 40 mg/m2.\n\n          -  Weight >= 12 kg.\n\n          -  Normal serum creatinine."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "firstreceived_date": "May 2, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00035074", 
            "org_study_id": "NCRR-M01RR00240-1757"
        }, 
        "intervention": {
            "intervention_name": "Methotrexate", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Methotrexate"
        }, 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19104"
                }, 
                "name": "Childrens Hospital of Philadelphia"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00035074"
        }, 
        "source": "National Center for Research Resources (NCRR)", 
        "sponsors": {
            "collaborator": {
                "agency": "Crohn's and Colitis Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2003"
    }, 
    "geocoordinates": {
        "Childrens Hospital of Philadelphia": "39.952 -75.164"
    }
}